Neoadjuvant chemo (NAC) has benefit in OPTICAL and FOxTROT!
👏🏽to all authors!
A 🧵
ascopubs.org/doi/10.1200/JC…
Jenny Seligmann

Dr. Nina Niu Sanford Krishan Jethwa Ibrahim Halil SAHIN, MD Aparna Raj Parikh Jonathan Loree Manju George MVSc PhD Rectal Cancer Survivor
Noam VanderWalde Chris Cann, MD
Retweets of this #videoShorts much appreciated!!
#CRCTrialsChat

Where *is* RT?

We wondered that too, so we asked Krishan Jethwa, Neil Newman, and Jeff Ryckman.

They offer over 1 hour of discussion on #RadOnc for liver tumors.

Add these eps to your Oncology Brothers to get the full multi-D team ♥️

I finally read CROSSFIRE (IRE vs. MRI-guided SBRT after chemo in locally advanced pancreas cancer) in detail.

There are a few issues. Brief thread.

thelancet.com/journals/langa…

Thank you ACRO - American College of Radiation Oncology and OncLive.com!

Just to elaborate on this. One of the points of my talk was that to optimize QOL, we have to appreciate there is much heterogeneity in locally advanced rectal cancer.

In this slide I presented below, both patients would be classified as LARC,…

As a rad onc res, I always wondered when preparing for clinic & conference:

“I must not be the 1st person to try to make sense of this”

As your rep for ARRO education, we can create more spaces for sharing resources

Here is an example from a rectal cancer NOM talk:

Few recent RadOnc factoids‼️
1.👍🏼👍🏼Fulfillment
2.👍🏼👍🏼Work hours
3.👍🏼👍🏼Compensation
But…
4.👎🏼👎🏼Job market

No surprise RadOnc was once a top 5 most competitive field.

I find my work incredibly rewarding!Congrats to those joining the field!

But WE have work to do‼️

🌟We're hiring a Rad Onc, focused on GI, to join our team Mayo Clinic Radiation Oncology Mayo Clinic in Rochester, MN!!🌟

We encourage any board certified/eligible practicing rad onc or graduating resident (including 2025 grads‼️‼️) to apply!

DM if questions!

jobs.mayoclinic.org/job/rochester/…

We are so excited to welcome these amazing #radonc 🌟superstars🌟! We can't wait for you to join the Mayo family 💙

Pleased to have contributed to design/conduct of study of ctDNA to screen for CRC; shows 83% sensitivity; 90% specificity. ⁦ASCO⁩ ⁦⁦ASCOPost⁩ AACR⁩ ⁦Fight Colorectal Cancer⁩ ⁦Mayo Clinic⁩ Mayo ClinicGIHep⁩ ⁦⁦American Gastroenterological Association (AGA)⁩ nejm.org/doi/full/10.10…

Orbital metastases from well diff NETs are well known and the primary NET is usually in the small bowel. This patient presented w/ mild diplopia on left horizonal gaze (had known SB NET). Small metastasis in the left lateral rectus muscle. Radiotherapy is very effective and safe.

New #VideoShorts from #CRCTrialsChat
A few short videos to explain a #colorectalcancer project🔥❤️
This series of videos are on the #DREAM -GI project-- a registry for MSI-H patients on neoadjuvant immunotherapy from Sakti Chakrabarti, MD!
Dr. Nina Niu Sanford Ibrahim Halil SAHIN, MD Krishan Jethwa
#CRCSM

Excited to see our 🔥 review challenging the dogma for treating brain metastasis. I hope to see more connectomics guided and memory avoiding treatments for our patients. academic.oup.com/neuro-oncology….

I am excited to share that we have officially launched an international HPB fellowship at #MayoClinic Rochester. A truly amazing opportunity for everyone seeking advanced HPB training. IHPBA E-AHPBA @EPHPBA SoMe4HPB Susanne Warner

Woohoo! #NEO -RT Trial activated ahead of schedule and ready to open! Thanks to all of the support!
Dr. Carl J Brown 🌎 CCTG NCI CTEP Clinical Research Josh Smith, MD, PhD, FACS Mark Whiteford Sharlene Gill, MD, MPH, MBA, FASCO Dr. Cathy Eng Karyn Goodman, MD, MS Jonathan Loree

A quick Xtorial:
1/10

1/ For #KidneyCancerAwareness month The Lancet Oncology has a 50-day full link to TROG Cancer Research FASTRACK II! authors.elsevier.com/a/1ifvZ5EIIgPd…. Thank you Cancer Australia, ANZUP, Varian. A new #radiotherapy standard of care option for inoperable primary #kidneycancer #radonc

This is my version of BCLC guidelines !